PLEASE NOTE: We've upgraded our registration system. Please create a new account to register if you haven't already done so. Please do not create multiple accounts. If you have forgotten your password, please choose "Login to Existing Account" then choose "Forgot Password."
|
|
|
| Overview | Objectives | Accreditation | Course Outline |
| Chairs | Faculty | Travel & Lodging | Cancellation Policy |
| Department: | Cardiology |
| Course Number: | MDM21A02 |
| Activity Start Date: | December 4, 2020 |
| Activity End Date: | December 6, 2020 |
| Location: | Virtual - Live Stream |
| Fees: | Early Bird Ends - 10/01/20 Regular Fee Begins - 10/02/20 |
Our 37th annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of cardiologic subspecialty interests including heart failure, cardiomyopathy, CAD, arrhythmias, lipid management, cannabis, COVID-19.
Our faculty will include a distinguished group of visiting academicians from North America together with outstanding teachers and clinicians from the University of California, San Francisco. The 2020 program has been designed for distance learning. The program will be live streamed over our course dates. All sessions will be recorded and made available to participants for online viewing 30 days post course.
TARGET AUDIENCE
This course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care nurses, and physician assistants.
LIVE STREAM MEETING
This course will be offered as a live interactive virtual conference. Login instructions along with the digital syllabus will be shared with attendees a week before the meeting. Included in your registration fee is access to the course recordings on demand (available within a week after the conference) for any sessions that you miss, available for up to 30 days post-course.
This course is intended to facilitate changes in practice with respect to:
The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
ABIM MOC Credits
American Board of Internal Medicine (ABIM) MOC- Successful completion of this CME activity enables the participant to earn up to 17.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
| Friday, December 4, 2020 | ||
| Time | Lecture | Speaker |
| 8:00 a.m. | Welcome and Overview | Peter Ganz, MD |
| 8:10 a.m. | Elliot Rapaport Keynote Lecture: Heart Failure with Preserved Ejection Fraction. | Scott Solomon, MD |
| 8:55 a.m. | Update on Hypertrophic Cardiomyopathy | Theodore Abraham, MD |
| 9:30 a.m. | Update on Lp(a) | Binh An P. Phan, MD, FACC |
| 10:05 a.m. | Coffee Break | |
| 10:25 a.m. | Native Valve Infective Endocarditis | Henry Chambers, MD |
| 11:00 a.m. | Myocardial Viability Testing and Coronary Revascularization in Ischemic Cardiomyopathy | John MacGregor, MD, PhD |
| 11:35 a.m. | Lunch Break | |
| 1:00 p.m. | Managing Cannabis Use in Patients with Cardiovascular Disease | Neal Benowitz, MD |
| 1:35 p.m. | Preoperative Assessment Before Non-Cardiac Surgery | Rachel Eshima-McKay, MD |
| 2:10 p.m. | Medical Management of Peripheral Artery Disease: A Contemporary Approach | Mark Creager, MD |
| 2:45 p.m. | Coffee Break | |
| 3:05 p.m. | Evaluation of Cryptogenic Strokes | J. Claude Hemphill, III, MD, MAS |
| 3:40 p.m. | Cardiac Rehabilitation: Present and Future | Alexis Beatty, MD, MAS |
| 4:15 p.m. | Adjourn | |
| Saturday, December 5, 2020 | ||
| Time | Lecture | Speaker |
| 8:10 a.m. | Welcome and Overview | Peter Ganz, MD |
| 8:15 a.m. | Cardiovascular Complications of COVID-19 | Priscilla Hsue, MD |
| 8:50 a.m. | ICU Management for COVID-19 Including Anticoagulation Strategies | Antonio Gomez, MD |
| 9:25 a.m. | An Update on COVID-19 Treatments and Vaccines | Annie Luetkemeyer, MD |
| 10:00 a.m. | Coffee Break | |
| 10:20 a.m. | Heart Failure with Recovered Ejection Fraction | James Fang, MD |
| 10:55 a.m. | SGLT2 Inhibitors for Heart Failure With or Without | Jonathan Davis, MD |
| Diabetes | ||
| 11:30 a.m. | Lunch Break | |
| 1:00 p.m. | Advances in LVADs and Other Mechanical | Liviu Klein, MD, MS |
| Supports | ||
| 1:35 p.m. | Management of Anti-Platelet and Anticoagulation Therapy in Patients with Stents | Mary Gray, MD |
| Christina Wang, Pharm D | ||
| 2:10 p.m. | Evaluation and Treatment of Patients with Mitral Valve Prolapse and Ventricular Arrhythmias | Edward Gerstenfeld, MD |
| 2:45 p.m. | Coffee Break | |
| 3:05 p.m. | Pathogeneses, Treatment and Cure of the Brugada Syndrome | Melvin Scheinman, MD |
| 3:40 p.m. | Subcutaneous vs. Transvenous Defibrillator | Joshua Moss, MD |
| 4:15 p.m. | Adjourn | |
| Sunday, December 6, 2020 | ||
| Time | Lecture Title | Speaker |
| 8:00 a.m. | Welcome and Overview | Peter Ganz, MD |
| 8:05 a.m. | Heart Failure and Iron Supplementation | Jamie Kennedy, MD, MS |
| 8:40 a.m. | Making Sense of the P2Y12 Inhibitors of Platelet | Krishan Soni, MD, MBA |
| Function at the Time and Following PCI | ||
| 9:15 a.m. | STEMI – Treating Culprit Lesion Only vs. Complete Revascularization | Krishan Soni, MD, MBA |
| 9:50 a.m. | Implementation and Clinical Utility of High Sensitivity Cardiac Troponin Assays | Rebecca Vigen, MD, MSCS |
| 10:25 a.m. | Coffee Break | |
| 10:40 a.m. | Debate: Management of left main coronary artery disease – PCI vs CABG | Lucas Zier, MD, MS |
| Arthur Hill, MD | ||
| 11:20 a.m. | Transcatheter Valve-in-Valve Implantation in Failed Aortic Bioprosthetic Valves | Jeffrey Zimmet, MD, PhD |
| 11:55 a.m. | Left Atrial Appendage Closure - When to Consider? | Thomas Dewland, MD |
| 12:30 p.m. | Effect of Bariatric Surgery on Cardiovascular Outcomes | Michael Crawford, MD |
| 1:05 p.m. | Adjourn |
COUSE DIRECTOR
Peter Ganz, MD, FACC
Chief, Division of Cardiology San Francisco General Hospital;
Maurice Eliaser Distinguished Professor of Medicine
CO-DIRECTORS
Mary Gray, MD
Binh An P. Phan, MD, FACC
Lucas Zier, MD, MS
Cancellations received in writing before December 1, 2020 will be refunded, less a $75 administrative fee. No refunds will be made on cancellations received after that date.
Please email your requests to RegEmail@ucsf.edu
